Globally Compliant Medium Chain Triglycerides Break International Supply Monopoly

GUANGZHOU, China – 2026 – Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., a state-owned high-tech pharmaceutical enterprise specializing in high-end excipients and APIs, announces its pharmaceutical-grade medium chain triglycerides (MCTs) are now globally available as a trusted, domestically produced alternative to imported supplies. This product addresses the core pain point of unstable supply for pharmaceutical and nutraceutical enterprises, featuring three key advantages: independent core technology, full compliance with international standards, and customizable manufacturing services. The company’s MCTs have been adopted by over 1,000 global clients, including leading firms like B. Braun Company and AstraZeneca.

Core Technological Breakthroughs & Product Highlights

1. Domestic Supply Independence: Hanfang successfully broke the long-term international monopoly on pharmaceutical MCTs, raising the domestic localization rate from 10% to 90% through independent R&D, ensuring stable supply for global clients
2. Green Manufacturing Technology: The company utilizes an innovative integrated green process combining supercritical CO₂ extraction, membrane separation, and chromatography, replacing traditional polluting production methods to meet environmental protection standards
3. Versatile Application Scenarios: As an API, solvent, and emulsifier, Hanfang’s MCTs are suitable for functional foods, medical nutrition products, and high-end injection preparations, catering to diverse enterprise needs

Global Compliance & Certifications

To meet global market access requirements, Hanfang’s pharmaceutical MCTs hold multiple international certifications, including EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI. These certifications ensure the product complies with regulatory standards in the EU, North America, Asia-Pacific, and other major global markets.

Supply & Customization Services

Hanfang’s pharmaceutical MCTs are now available for global pre-order through the official website and authorized distributors. The company also offers customized manufacturing services to meet the specific needs of different industries and projects, including tailored specifications and packaging solutions.

Executive Quote

"Our pharmaceutical MCTs are a key achievement in addressing the 'bottleneck' issues in high-end pharmaceutical excipients," said Xu Wendong, General Manager and Deputy Director of the National Engineering Research Center at Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. "We will continue to leverage our technological advantages to provide reliable, high-quality domestic alternatives for global pharmaceutical and nutraceutical partners."

Industry Context & Strategic Alignment

Against the backdrop of global supply chain volatility, the demand for localized, compliant pharmaceutical excipients is rapidly growing. Hanfang’s launch of domestically produced MCTs aligns with this trend, strengthening global supply chain resilience while supporting the self-reliance of the pharmaceutical industry.

Future Plans

Looking ahead, Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. will continue to invest in R&D for high-end pharmaceutical lipids, expand its global sales and service network, and target double-digit revenue growth in 2026 as part of its strategic initiatives.

About Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.

Founded in 1998, Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. is a wholly state-owned subsidiary of the Fortune Global 500 Guangzhou Pharmaceutical Holdings. As a national specialized, sophisticated, unique, and new "Little Giant" enterprise, it operates the only national engineering research center for traditional Chinese medicine pharmaceutical technology, with over 240 patents and products sold in more than 30 countries. The company’s mission is to achieve technological self-reliance, break supply bottlenecks, and safeguard pharmaceutical industry chain security. For more information, visit http://byshanhanfang.com/.

Contact Information

Company: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
Official Website: http://byshanhanfang.com/

© 2026 Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. All rights reserved.